Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
112 studies found for:    therapeutic HPV vaccine
Show Display Options
Rank Status Study
1 Recruiting Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia
Conditions: Anal Intraepithelial Neoplasia;   HIV
Intervention: Drug: HPV-16 vaccine
2 Enrolling by invitation Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL
Condition: Cervical High Grade Squamous Intraepithelial Lesion
Intervention: Biological: Human Papillomavirus vaccine
3 Withdrawn Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory Papillomatosis
Condition: Recurrent Respiratory Papillomatosis
Intervention: Biological: Human Papillomavirus Vaccine
4 Completed
Has Results
Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy
Condition: Inflammatory Bowel Disease
Intervention: Biological: Gardasil vaccine
5 Recruiting Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer
Conditions: Cancer of Head and Neck;   Cancer of Cervix;   Cancer of Anus
Interventions: Drug: DPX-E7 vaccine;   Drug: Cyclophosphamide
6 Completed Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention
Condition: Cervical Cancer
Intervention: Biological: HPV Vaccine (Gardasil)
7 Not yet recruiting Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts
Condition: Genital Warts
Interventions: Biological: Quadrivalent HPV vaccine;   Biological: Hepatitis B vaccine
8 Recruiting Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Conditions: Cervical Intraepithelial Neoplasia;   Cervical Dysplasia
Interventions: Drug: 9-valent HPV vaccine;   Drug: Imiquimod
9 Completed A Phase I Clinical Trial of an HPV Therapeutic Vaccine
Condition: Human Papillomavirus
Intervention: Biological: Vaccine consisting of four HPV-16 E6 peptides in combination with Candin®
10 Active, not recruiting HPV Vaccination in Special Risk Groups: 5 Year Follow-up
Conditions: PRD (Paediatric Rheumatological Disease);   IBD (Inflammatory Bowel Disease)
Intervention:
11 Completed Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)
Conditions: Cervical Cancer;   Genital Warts
Interventions: Biological: V501, Gardasil, Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine / Duration of Treatment : 4 Years;   Biological: Comparator: placebo (concomitant-vaccine matched) / Duration of Treatment : 4 Years
12 Active, not recruiting Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.
Conditions: Transplantation;   Systemic Lupus Erythematosus;   Systemic Immune Disease
Intervention: Biological: HPV prophylactic vaccine Gardasil
13 Not yet recruiting 4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children
Condition: Recurrent Respiratory Papillomatosis
Intervention: Biological: 4-valent HPV vaccine
14 Recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors
Conditions: Cancer Survivor;   Prevention of Human Papillomavirus Infection
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine or nonavalent human papillomavirus vaccine (HPV 6, 11, 16, 18, 31, 33, 45, 52, 58);   Other: laboratory biomarker analysis;   Other: survey administration;   Other: medical chart review
15 Completed
Has Results
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection
Conditions: Infection;   Precancerous Condition
Intervention: Biological: Gardasil
16 Recruiting HPV (Human Papilloma Virus) Vaccination After Treatment of Anal Intraepithelial Neoplasia (AIN)
Conditions: AIN;   HIV
Interventions: Biological: Gardasil;   Drug: Placebo
17 Recruiting Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia
Conditions: Cervical Cancer;   Precancerous Condition;   HPV Disease;   Human Papilomavirus
Interventions: Biological: TA-HPV;   Biological: pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine;   Drug: imiquimod
18 Recruiting Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Cyclophosphamide;   Biological: DRibble vaccine;   Drug: Imiquimod;   Drug: GM-CSF;   Biological: HPV vaccine
19 Enrolling by invitation Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities
Condition: Papillomavirus Infections
Intervention: Biological: human papillomavirus vaccine L1, type 6,11,16,18
20 Completed
Has Results
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
Conditions: Cervical Cancer;   Nonneoplastic Condition;   Precancerous Condition
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine;   Genetic: DNA analysis;   Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Procedure: colposcopic biopsy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.